Survival benefits of primary tumor surgery for synchronous brain metastases: A SEER ‐based population study with propensity‐matched comparative analysis | | |
Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas | | 2022 |
Combinatory anti-tumor activities of AQ4 and temsirolimus against colorectal cancer cells | | |
Diverting ileostomy is a risk factor for renal impairment during CAPOX therapy | | |
Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer | | |
Malignancies in HIV | | 2021 |
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study | Cancers | 2022 |
Role of Neoadjuvant therapy in the treatment of patients with colorectal liver metastases | | 2023 |
Up-to-date evidence on image-guided thermal ablation for metastatic lung tumors: a review | Japanese Journal of Radiology | |
WEO newsletter | Digestive Endoscopy | 2022 |
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA | Clinical Epigenetics | 2022 |
Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study | BMC Gastroenterology | 2022 |
Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy | Cancers | 2022 |
The role of high-risk features in stage II colon cancer after surgical treatment | Surgery Open Digestive Advance | 2022 |
Perioperative and oncologic outcomes of interval colectomy performed by acute care surgeons after stenting as a bridge to surgery for left-sided malignant colonic obstruction are non-inferior to the outcomes of colorectal surgeons in the elective setting: single center experience | European Journal of Trauma and Emergency Surgery | |
Disparities in Surgical Timing and Guideline-Adherent Staging Work-Up for Colon Cancer | Annals of Surgical Oncology | |
Local Therapies for Colorectal Cancer Oligometastases to the Lung | Current Colorectal Cancer Reports | 2022 |
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC) | Cancers | 2022 |
Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer | PLoS ONE | 2022 |
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3 | British Journal of Cancer | |
Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping | Clinical Pharmacology and Therapeutics | |
PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies | Cancers | 2022 |
Comparison of survival outcomes using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colon versus rectal cancer with peritoneal carcinomatosis in an asian medical center | Journal of Cancer Research and Practice | 2022 |
CPI Adult Cancer Imaging Special Edition Module | | 2019 |
Tumor Stroma Ratio and Its Significance in Locally Advanced Colorectal Cancer | Current Oncology | 2022 |
Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy. | Targeted Oncology | 2022 |
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort | Cancers | 2022 |
Comprehensive Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of a Real-World Healthcare Claims Database | Current Oncology | 2022 |
Extended Lymphadenectomy for Proximal Transverse Colon Cancer: Is There a Place for Standardization? | Medicina (Lithuania) | 2022 |
THINKING TOO FAST ABOUT CHEMOTHERAPY FOR RESECTABLE COLORECTAL CANCER LIVER METASTASES? | Clinical Colorectal Cancer | 2022 |
Concordance analysis between liquid biopsy (ctDNA) and tumor DNA molecular profiles from panel-based next-generation sequencing | Revista Espanola De Patologia | 2022 |
Image_2.pdf | | 2020 |
Image_1.pdf | | 2020 |
Data_Sheet_1.pdf | | 2020 |
Data_Sheet_1.PDF | | 2020 |
Pelvic CT in addition to MRI to differentiate between rectal and sigmoid cancer on imaging using the sigmoid take-off as a landmark. | Acta Radiologica | 2022 |
Prognostic significance of the mean corpuscular volume (MCV) and red cell distribution width (RDW) in obstructive colorectal cancer patients with a stent inserted as a bridge to curative surgery. | Surgery Today | 2022 |
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial. | British Journal of Cancer | 2021 |
9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells. | Frontiers in Pharmacology | 2021 |
Advanced Endoscopic Resection Techniques: Endoscopic Submucosal Dissection and Endoscopic Full-Thickness Resection. | Digestive Diseases and Sciences | 2022 |
Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data. | Pharmacogenomics Journal | 2022 |
Society for Surgery of the Alimentary Tract Health Care Quality and Outcomes Committee Webinar: Addressing Disparities. | Journal of Gastrointestinal Surgery | 2022 |
A risk stratification for nodal metastasis in T1 colorectal cancer after successful therapeutic endoscopy. | Gastrointestinal Endoscopy | 2022 |
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen. | Journal of Cancer Research and Clinical Oncology | 2022 |
High Red Cell Distribution Width Is Associated with Worse Prognosis in Early Colorectal Cancer after Curative Resection: A Propensity-Matched Analysis. | Cancers | 2022 |
Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study. | Frontiers in Oncology | 2022 |
Efficacy and Safety of Systemic Treatments Among Colorectal Cancer Patients: A Network Meta-Analysis of Randomized Controlled Trials. | Frontiers in Oncology | 2021 |
Classification of early-stage colon cancer with Immunoscore: clinical evidence and case studies. | Future Oncology | 2021 |
The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients. | Molecular Diagnosis and Therapy | 2022 |
Circulating Tumor Cell Kinetics and Morphology from the Liquid Biopsy Predict Disease Progression in Patients with Metastatic Colorectal Cancer Following Resection. | Cancers | 2022 |